Filter
2180
Text search:
ART
drugs
Featured
Recommendations
181
New Publications
661
Language
Document type
No document type
1536
Guidelines
237
Studies & Reports
212
Manuals
70
Strategic & Response Plan
37
Training Material
35
Fact sheets
29
Infographics
9
Situation Updates
7
Brochures
4
Resource Platforms
3
Countries / Regions
India
141
Kenya
80
Zambia
64
South Africa
64
Tanzania
58
Ethiopia
55
Malawi
53
Nigeria
50
Uganda
46
Nepal
39
Rwanda
39
Western and Central Europe
37
Liberia
35
Myanmar / Burma
34
Global
33
Namibia
32
Ghana
31
Lesotho
30
Africa
30
Bangladesh
28
Sierra Leone
24
Ukraine
24
Eastern Europe
24
Asia
22
Zimbabwe
21
Cambodia
20
Latin America and the Carribbean
18
Senegal
17
Botswana
17
Philippines
16
South–East Asia Region
14
Mozambique
13
Eswatini/ Swaziland
13
Indonesia
11
Venezuela
9
Albania
9
Cameroon
8
Germany
8
Russia
8
Congo, Democratic Republic of
7
Tajikistan
7
Haiti
6
Pakistan
6
Syria
6
Brazil
6
Georgia
6
Burkina Faso
5
Colombia
5
Paraguay
5
Thailand
4
Benin
4
Yemen
4
East and Southern Africa
4
Armenia
4
Guinea
3
South Sudan
3
Afghanistan
3
Central African Republic
3
Argentina
3
West and Central Africa
3
Bhutan
3
Estonia
3
Romania
3
Vietnam
3
Somalia
2
Lebanon
2
Sudan
2
North Macedonia
2
Serbia
2
Ecuador
2
Sri Lanka
2
Middle East and North Africa
2
Timor Leste/ East Timor
2
Moldova
2
Uzbekistan
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Saudi Arabia
1
Niger
1
Iraq
1
Jordan
1
Egypt
1
Gambia
1
China
1
Papua New Guinea
1
Peru
1
Hungary
1
Burundi
1
Bolivia
1
Greece
1
Libya
1
Madagascar
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Poland
1
Palestine
1
North Korea
1
Djibouti
1
Southern Africa
1
Laos
1
Canada
1
Qatar
1
Bulgaria
1
Lithuania
1
Iran
1
Australia
1
Uruguay
1
Turkmenistan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
990
Clinical Guidelines
172
Women & Child Health
71
Public Health
53
Capacity Building
51
Key Resources
45
Pharmacy & Technologies
17
Annual Report MEDBOX
1
Toolboxes
HIV
562
TB
241
Mental Health
108
Pharmacy
45
Caregiver
44
NTDs
31
COVID-19
27
AMR
26
Refugee
25
Disability
18
Conflict
14
Global Health Education
14
Health Financing Toolbox
12
Malaria
11
Planetary Health
10
NCDs
9
Natural Hazards
8
Rapid Response
8
Social Ethics
7
Ebola & Marburg
6
Polio
4
2.0 Rapid Response
3
Cholera
2
Zika
2
Specific Hazards
1
People Who Inject Drugs
In addition, the following individuals of our external expert advisory committee made instrumental contributions to the initial design and content of the document: Billy Pick, USAID; Daniel Wolfe, Open Society Foundations;
...
People living with HIV depend on life-saving antiretroviral therapy (ART) and access to ART must be maintained during periods of travel restrictions and lockdowns resulting from the COVID-19 pandemi
...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (
...
Version 1.1 July 2016
The purpose of this document is to describe standard operating procedures for viral load monitoring, including the schedule for viral load testing when used for routine monitoring of children, adolescents and adults on ART ...
The purpose of this document is to describe standard operating procedures for viral load monitoring, including the schedule for viral load testing when used for routine monitoring of children, adolescents and adults on ART ...
Reporting period: January 2014 – December 2014
The human immunodeficiency virus (HIV) epidemic in Myanmar is concentrated among men who have sex with men (MSM), people who inject drugs (PWID) and female sex workers (FSW). HIV prevalence in th ...
The human immunodeficiency virus (HIV) epidemic in Myanmar is concentrated among men who have sex with men (MSM), people who inject drugs (PWID) and female sex workers (FSW). HIV prevalence in th ...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (
...
The curriculum, which complements the national pediatric ART training, was finalized in 2011 and was subsequently implemented nationally. The training curriculum includes a 15-module Trainer Manual, a Participant Manual, and accompanying PowerPoint
...
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur, India. The study is one of the first qualitative comparative studies to seek an in-depth understandin
...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in
...
Q1: In individuals with psychotic disorders (including schizophrenia), are antipsychotic drugs safe and effective?
Due to the anticipated significant rise in VL testing occasioned by Ghana’s adaptation of 2016 ART guidelines, it has become necessary to develop this VL scale-up and operational plan to assure complete client access to laboratory monitoring towar
...
TB heroes
Hello, my name is Nurse X
My job is to promote integrated HIV and TB prevention, care, treatment and support. This ensures that we, and my team of health care service providers treat everyone who is living with HIV and TB to have all the antiretroviral therapy (
...
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this
...
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after fai
...
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
